Erin Stewart joined Ropes & Gray’s Washington D.C. office in 2021 as an associate in the Litigation & Enforcement Practice Group. Erin’s practice includes government and internal investigations across a variety of industries involving various government agencies. She has experience representing corporate clients in matters involving allegations of Foreign Corrupt Practices Act violations, False Claims Act violations, and violations of securities laws. She also advises clients on compliance risks and conducts pre- and post-acquisition due diligence in M&A transactions. Erin’s practice also includes complex commercial litigation in federal court.

Erin maintains an active pro bono practice. She represents asylum applicants, serves as counsel to a DC-based coalition, has advised on matters related to Social Security disability benefits, and has assisted the Michigan State Appellate Defender’s Office with juvenile re-sentencing efforts.

During law school, Erin served as a Legal Research and Writing Fellow, a Senior Writing Fellow, and the Academic Chair of the Women’s Legal Alliance. Erin also placed second in the 2020 Iron Tech Lawyer Competition.


  • Represented a pharmaceutical company in conducting an internal investigation of whistleblower reports regarding possible violations of the FCPA, securities laws, and employment laws.
  • Represented a foreign shipping and oil company in connection with an internal investigation regarding accusations of bribery and corruption.
  • Assists private equity sponsors and their portfolio companies in identifying, assessing, and mitigating corruption, sanctions, and money-laundering risks related to various transactions and investments.
  • Drafted training presentations on various topics, including attorney-client privilege, effective compliance programs, and FCPA, AKS, FDCA, FCA, and HIPAA compliance.
  • Conducting a proactive review of a major technology company’s internal investigation structure, processes, and functions.
  • Conducted a proactive review of a major pharmaceutical company’s U.S. policies and practices and advised on various compliance risks.
  • Represents a major clothing manufacturer in connection with multiple consumer class actions alleging fraudulent and deceptive trade practices.
  • Represents various universities and academic institutions in conducting internal investigations and responding to government inquiries related to allegations of “foreign influence” and research misconduct.
  • Represents a medical care provider in connection with a government inquiry and internal investigation into potential violations of the False Claims Act.
  • Represents a national pharmacy in fraud and consumer fraud lawsuits based on retail pharmaceutical drug pricing.
  • Conducted an independent review of a biopharmaceutical company’s monitoring assessment targeting policy violations creating potential Anti-Kickback Statute risk.
  • Assisted with a policies and practices review for a high-profile association, which informed its efforts to implement a comprehensive multi-year diversity, equity, and inclusion strategy.
  • Conducted an internal investigation of a biotechnology company into whistleblower claims regarding potential securities violations in connection with vaccine manufacturing and trials.

Areas of Practice